1. Home
  2. CBSH vs IBRX Comparison

CBSH vs IBRX Comparison

Compare CBSH & IBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Commerce Bancshares Inc.

CBSH

Commerce Bancshares Inc.

N/A

Current Price

$55.65

Market Cap

8.0B

Sector

Finance

ML Signal

N/A

Logo ImmunityBio Inc.

IBRX

ImmunityBio Inc.

N/A

Current Price

$6.10

Market Cap

8.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CBSH
IBRX
Founded
1865
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.0B
8.2B
IPO Year
2008
2015

Fundamental Metrics

Financial Performance
Metric
CBSH
IBRX
Price
$55.65
$6.10
Analyst Decision
Hold
Strong Buy
Analyst Count
10
4
Target Price
★ $64.06
$14.25
AVG Volume (30 Days)
952.3K
★ 13.2M
Earning Date
10-20-2026
11-09-2026
Dividend Yield
★ 1.98%
N/A
EPS Growth
4.39
★ 38.71
EPS
★ 3.14
N/A
Revenue
N/A
★ $113,288,000.00
Revenue This Year
$12.04
$99.98
Revenue Next Year
$3.42
$108.29
P/E Ratio
$17.66
★ N/A
Revenue Growth
N/A
★ 668.31
52 Week Low
$46.99
$1.95
52 Week High
$60.92
$12.43

Technical Indicators

Market Signals
Indicator
CBSH
IBRX
Relative Strength Index (RSI) 49.67 33.03
Support Level $54.23 $5.58
Resistance Level $56.26 $8.62
Average True Range (ATR) 1.04 0.60
MACD 0.05 -0.27
Stochastic Oscillator 37.69 7.53

Price Performance

Historical Comparison
CBSH
IBRX

About CBSH Commerce Bancshares Inc.

Commerce Bancshares Inc operates as the bank holding company for Commerce Bank. The bank is engaged in the general banking business, providing a broad range of retail, mortgage banking, corporate, investment, trust, and asset management products and services to individuals, businesses, and municipalities. The company has three reportable segments. The Commercial segment provides lending, leasing, deposit, payment, and cash management services to business and government customers. The Retail Banking segment offers consumer deposits, consumer lending, mortgage banking, and debit and credit card services through its branch network. The Wealth segment provides trust, estate planning, brokerage, and investment management services to individual and institutional clients.

About IBRX ImmunityBio Inc.

ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.

Share on Social Networks: